<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02271971</url>
  </required_header>
  <id_info>
    <org_study_id>14-412</org_study_id>
    <nct_id>NCT02271971</nct_id>
  </id_info>
  <brief_title>Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Psoriasis</brief_title>
  <official_title>Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Moderate to Severe Psoriasis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pontificia Universidad Catolica de Chile</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pontificia Universidad Catolica de Chile</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether supplementation with oral vitamin D
      (cholecalciferol) improves metabolic parameters in patients with moderate to severe
      psoriasis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Total Cholesterol Levels</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Fasting Glucose Levels</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in HOMA Index</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Glycated Hemoglobin Levels</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Low-Density Lipoprotein Levels</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in High-Density Lipoprotein Levels</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Triglycerides Levels</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in C-Reactive Protein Levels</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Vitamin D Levels</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in PASI (Psoriasis Area Severity Index)</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of Participants with Adverse Events</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">39</enrollment>
  <condition>Psoriasis</condition>
  <condition>Metabolic Syndrome</condition>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>Vitamin D3 supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in the experimental arm will receive a daily 5.000 IU vitamin D3 capsule during 6 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects in the placebo arm will receive a daily placebo capsule during 6 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D3</intervention_name>
    <description>A daily 5.000 IU vitamin D3 capsule during 6 weeks.</description>
    <arm_group_label>Vitamin D3 supplementation</arm_group_label>
    <other_name>Cholecalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>A daily placebo capsule during 6 weeks.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of moderate to severe psoriasis.

          -  Being treated with methotrexate with stable doses for al least 1 month.

        Exclusion Criteria:

          -  Phototherapy within the past 2 months.

          -  History of psoriatic arthritis, rheumatoid arthritis, type 1 diabetes mellitus or
             inflammatory bowel disease.

          -  Use of vitamin d supplements or fish oil supplements in the past 2 months.

          -  Use of hypolipidemic drugs, hypoglycemic drugs, glucose sensitizers, oral
             corticosteroids, orlistat, cholestyramine, phenobarbital or phenytoin within the past
             2 months.

          -  Pregnancy or lactation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sergio Niklitschek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>School of Medicine, Pontificia Universidad Católica de Chile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ninoska Porras, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>School of Medicine, Pontificia Universidad Católica de Chile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hernán Correa, MD</last_name>
    <role>Study Director</role>
    <affiliation>School of Medicine, Pontificia Universidad Católica de Chile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Félix Fich, MD</last_name>
    <role>Study Director</role>
    <affiliation>School of Medicine, Pontificia Universidad Católica de Chile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Isidora Harz, MD</last_name>
    <role>Study Director</role>
    <affiliation>School of Medicine, Pontificia Universidad Católica de Chile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arturo Borzutzky, MD</last_name>
    <role>Study Director</role>
    <affiliation>School of Medicine, Pontificia Universidad Católica de Chile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luis Villarroel, MD</last_name>
    <role>Study Director</role>
    <affiliation>School of Medicine, Pontificia Universidad Católica de Chile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William Romero, MD</last_name>
    <role>Study Director</role>
    <affiliation>School of Medicine, Pontificia Universidad Católica de Chile</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pontificia Universidad Católica de Chile</name>
      <address>
        <city>Santiago</city>
        <state>Región Metropolitana</state>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 19, 2014</study_first_submitted>
  <study_first_submitted_qc>October 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 22, 2014</study_first_posted>
  <last_update_submitted>November 3, 2015</last_update_submitted>
  <last_update_submitted_qc>November 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 4, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Psoriasis</keyword>
  <keyword>Vitamin D</keyword>
  <keyword>Metabolic syndrome</keyword>
  <keyword>Insulin resistance</keyword>
  <keyword>Cholesterol</keyword>
  <keyword>Methotrexate</keyword>
  <keyword>Dyslipidemia</keyword>
  <keyword>PASI</keyword>
  <keyword>Psoriasis Area Severity Index</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psoriasis</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

